Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 14;11(10):2459.
doi: 10.3390/nu11102459.

Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence

Affiliations

Nutritional and Metabolic Characteristics of UK Adult Phenylketonuria Patients with Varying Dietary Adherence

Benjamin Green et al. Nutrients. .

Abstract

The nutritional and metabolic characteristics of adult phenylketonuria (PKU) patients in the UK with varying dietary adherence is unknown. In other countries, nutritional and metabolic abnormalities have been reported in nonadherent patients compared to adherent counterparts. A pooled analysis of primary baseline data from two UK multi-centre studies was therefore performed to establish whether this is true from a UK perspective. Adult PKU patients who had provided 3-day food records and amino acid blood samples were included and grouped according to dietary adherence (adherent; n = 16 vs. nonadherent; n = 14). Nonadherent patients consumed greater amounts of natural protein compared to adherent patients (61.6 ± 30.7 vs. 18.3 ± 7.7 g/day; q < 0.001). In contrast, the contribution of protein substitutes to total protein intake was lower in nonadherent compared to adherent patients (3.9 ± 9.2 g/day vs. 58.6 ± 10.2 g/day; q < 0.001). Intakes of iron, zinc, vitamin D3, magnesium, calcium, selenium, iodine, vitamin C, vitamin A and copper were significantly lower in nonadherent compared to adherent patients and were below UK Reference Nutrient Intakes. Similarly, intakes of thiamin, riboflavin, niacin, vitamin B6 and phosphorus were significantly lower in nonadherent compared to adherent patients but met the UK Reference Nutrient Intakes. Phenylalanine concentrations in nonadherent patients were significantly higher than adherent patients (861 ± 348 vs. 464 ± 196 µmol/L; q=0.040) and fell outside of European treatment target ranges. This study shows the nutritional and metabolic consequences of deviation from phenylalanine restriction and intake of PKU protein substitutes in nonadherent adult PKU patients. Collectively, these data further underlie the importance of life-long adherence to the PKU diet.

Keywords: Nonadherence; PKU; Phenylalanine; Phenylketonuria; adherence; nutrient intake.

PubMed Disclaimer

Conflict of interest statement

BG, RB, HC, GH and RS are employees of Nutricia Ltd. Have received educational grants from Nutricia Ltd for conference attendance: SA (Sarah Adam), CN, SA (Sandra Adams), CD, MH, KKH, RS (Rachel Skeath), PH, LG, CF and CN. Have received honorarium from Nutricia Ltd for conference presentation: SA (Sandra Adams), LR and LG. Have provided scientific advice and expertise for Nutricia Advisory Boards: YR, SA (Sarah Adam), LR, CD, KKH, CF and CN. Declare no competing interests with the study funder: SF, FJ, CD, AC, IH, SD, AS, VB.

Figures

Figure 1
Figure 1
Contribution of low-phenylalanine protein substitutes (expressed as protein equivalents) and natural protein to total protein intake of adherent and nonadherent patients. White shaded bars [⬜] represent protein equivalents from low-phenylalanine protein substitutes whereas grey shaded bars [⬛] represent natural protein intake.
Figure 2
Figure 2
Nutrient intake is depicted as percent deviation from age and gender specific UK reference nutrient intakes. Tukey box and whisker plot. Grey shaded boxes [⬛] represent the adherent patients, whereas white shaded boxes [⬜] represent values obtained from the nonadherent population.

References

    1. De Groot M.J., Hoeksma M., Blau N., Reijngoud D.J., van Spronsen F.J. Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses. Mol. Genet. Metab. 2010;99:S86–S89. doi: 10.1016/j.ymgme.2009.10.016. - DOI - PubMed
    1. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet. 2010;376:1417–1427. doi: 10.1016/S0140-6736(10)60961-0. - DOI - PubMed
    1. Macdonald A., Daly A., Davies P., Asplin D., Hall S.K., Rylance G., Chakrapani A. Protein substitutes for PKU: What’s new? J. Inherit. Metab. Dis. 2004;27:363–371. doi: 10.1023/B:BOLI.0000031099.79046.65. - DOI - PubMed
    1. Van Spronsen F.J., de Groot M.J., Hoeksma M., Reijngoud D.-J., van Rijn M. Large neutral amino acids in the treatment of PKU: From theory to practice. J. Inherit. Metab. Dis. 2010;33:671–676. doi: 10.1007/s10545-010-9216-1. - DOI - PMC - PubMed
    1. Rocha J.C., Martel F. Large neutral amino acids supplementation in phenylketonuric patients. J. Inherit. Metab. Dis. 2009;32:472. doi: 10.1007/s10545-009-1132-x. - DOI - PubMed

Grants and funding